文献速递神经技术与安全CT

两种直线加速器立体定向放射外科系统治疗单发与多发脑转移瘤的剂量学性能比较

Dosimetric performance of two linear accelerator-based radiosurgery systems to treat single and multiplebrain metastases.
PubMed 文献 · Br J Radiol · 2019-06-12

本研究比较了基于直线加速器的HyperArc与射波刀CyberKnife_G4治疗24例患者31个脑转移瘤的剂量学计划质量。单发脑转移时HyperArc正常脑组织受量显著低于CyberKnife_G4且与PTV强相关;多发脑转移时两系统除高剂量区外无显著差异;HyperArc出束时间更短(5.6±0.8 min vs 15.8±5.3 min,p<.01)。结论认为HyperArc最适合单发较大靶区及多发脑转移瘤间距较小的情况。

要点

  • 单发脑转移时HyperArc正常脑组织受量显著低于CyberKnife_G4,且差异与PTV强相关。
  • 多发脑转移时两系统除正常组织高剂量区外无显著差异。
  • 靶区间最大距离超过8.0 cm时,脑减PTV低剂量区HyperArc剂量高于CyberKnife_G4。

核心结论

  • HyperArc最适合单发脑转移中的较大靶区以及多发脑转移中间距较小的肿瘤。

研究设计与样本

  • 研究论文;24例患者的31个肿瘤接受CyberKnife立体定向放射外科治疗,CT图像、结构集和剂量文件转入Eclipse治疗计划系统用于HyperArc计划,比较两计划剂量学参数,由总机器跳数和剂量率计算出束时间。

关键影像表现/征象

  • 单发脑转移时,正常脑组织接受体积剂量HyperArc显著低于CyberKnife_G4,且与PTV强相关。
  • 单发脑转移时,CyberKnife_G4与HyperArc的体积剂量差异与PTV成比例。
  • 多发脑转移时,两系统除正常组织高剂量区外无显著差异。
  • 脑减PTV低剂量区,靶区间最大距离超过8.0 cm时HyperArc剂量高于CyberKnife_G4。

诊断标准与关键数值

  • 出束时间均值±标准差:CyberKnife_G4为15.8±5.3 min,HyperArc为5.6±0.8 min(p<.01)。

临床应用与阅片要点

  • 单发脑转移且靶区较大时可优先考虑HyperArc计划以降低正常脑组织受量。
  • 多发脑转移且靶区间距较小时HyperArc剂量学表现与CyberKnife_G4相当。
  • 靶区间最大距离超过8.0 cm时需注意脑减PTV低剂量区HyperArc剂量高于CyberKnife_G4。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate and compare the dosimetric plan quality for noncoplanar volumetric arc therapy of single and multiple brain metastases using the linear accelerator-based radiosurgery system HyperArc and a robotic radiosurgery system.

METHODS: 31 tumors from 24 patients were treated by stereotactic radiosurgery using the CyberKnife system. CT images, structure sets, and dose files were transferred to the Eclipse treatment planning system for the HyperArc system. Dosimetric parameters for both plans were compared. The beam-on time was calculated from the total monitor unit and dose rate.

RESULTS: For normal brain tissue, the received volume doses were significantly lower for HyperArc than for CyberKnife_G4 and strongly correlated with the planning target volume (PTV) for cases of single brain metastasis. In addition, the difference in volume dose between CyberKnife_G4 and HyperArc was proportional to the PTV. For multiple brain metastases, no significant difference was observed between the two stereotactic radiosurgery systems, except for high-dose region in the normal tissue. In low dose for brain minus PTV, when the maximum distance among each target was above 8.0 cm, HyperArc delivered higher dose than CyberKnife_G4. The mean ± SDs for the beam-on time were 15.8 ± 5.3 and 5.6 ± 0.8 min for CyberKnife_G4 and HyperArc, respectively (p < .01).

CONCLUSION: HyperArc is best suited for larger targets in single brain metastasis and for smaller inter tumor tumor distances in multiple brain metastases.

ADVANCES IN KNOWLEDGE: The performance of HyperArc in comparison with CyberKnife_G4 was depended on defined margin and tumor distances.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ueda Y, Ohira S, Yamazaki H, et al. Dosimetric performance of two linear accelerator-based radiosurgery systems to treat single and multiplebrain metastases. Br J Radiol. 2019. PMID: 31188018. doi:10.1259/bjr.20190004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。